Evonik Evonik

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    Find the latest Drugs in Development and Pipeline Prospector News of Biomm.

    Client Virtual Booth

    BIOMM

    EVENTS

    • Webinars & Exhibitions

    PRESENTATION(s)

    VIDEO(s)

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass
    Contact SupplierContact Supplier
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Send me more info on How To Grow My Bussiness Digitally?
    Biomm
    Brazil Flag
    Country
    Country
    Brazil
    Address
    Address
    Rua dos Pinheiros, 610 – 8º andarcj 81Pinheiros São Paulo SP 05422-001
    Telephone
    Telephone
    0800-0572466
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://biomm.com/en/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/biommoficial/
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Full View ScreenFull Screen View
    • Deals
    Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE

    Biocon Partners Biomm to Commercialise Diabetes Drug in Brazil

    Details:

    Under the terms of the partnership, Biocon will undertake the development, manufacturing and supply of Ozempic (semaglutide), and Biomm will be responsible for obtaining regulatory approval and commercialization in the Brazilian market.


    Lead Product(s): Semaglutide

    Therapeutic Area: Endocrinology Product Name: Ozempic

    Highest Development Status: ApprovedProduct Type: Peptide

    Recipient: Biocon

    Deal Size: Undisclosed Upfront Cash: Undisclosed

    Deal Type: Partnership April 17, 2024

    ASK
    US
    PHARMACOMPASS
    Upload
    your Marketing & Sales content
    • Deals
    Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE

    Bio-Thera Solutions Expands Partnership with Biomm in Brazil with Addition of BAT2206, a Stelara® Biosimilar

    Details:

    Under the agreement, Biomm will have exclusive rights to distribute and market BAT2206 (ustekinumab), a proposed biosimilar to Janssen’s Stelara, in Brazil for the treatment of active psoriatic arthritis.


    Lead Product(s): Ustekinumab

    Therapeutic Area: Dermatology Product Name: BAT2206

    Highest Development Status: Phase IIIProduct Type: Large molecule

    Recipient: Bio-Thera Solutions

    Deal Size: Undisclosed Upfront Cash: Undisclosed

    Deal Type: Licensing Agreement June 16, 2023

    ASK
    US
    PHARMACOMPASS
    Upload
    your Marketing & Sales content
    • Deals
    Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE

    Lupin and Biomm Enter into a Distribution and Marketing Agreement for Pegfilgrastim in Brazil

    Details:

    Under the terms of agreement, Biomm will distribute and market biosimilar Pegfilgrastim in Brazil. Pegfilgrastim is indicated to reduce the duration of neutropenia and the incidence of febrile neutropenia in patients receiving chemotherapy.


    Lead Product(s): Pegfilgrastim

    Therapeutic Area: Oncology Product Name: Lupifil-P

    Highest Development Status: Phase IIIProduct Type: Large molecule

    Partner/Sponsor/Collaborator: Lupin Ltd

    Deal Size: Undisclosed Upfront Cash: Undisclosed

    Deal Type: Agreement December 03, 2021

    ASK
    US
    PHARMACOMPASS
    Upload
    your Marketing & Sales content
    • Development Update
    Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE

    Biomm S.A. Announces Plans to Submit Authorization to Conduct Phase 3 Clinical Studies of Leronlimab with ANVISA in Brazil

    Details:

    Marketed as Vyrologix, leronlimab is an investigational humanised immunoglobulin G4 monoclonal antibody that hinders C-C chemokine receptor type 5 (CCR5).


    Lead Product(s): Leronlimab

    Therapeutic Area: Infections and Infectious Diseases Product Name: Vyrologix

    Highest Development Status: Phase IIIProduct Type: Large molecule

    Partner/Sponsor/Collaborator: Not Applicable

    Deal Size: Not Applicable Upfront Cash: Not Applicable

    Deal Type: Not Applicable May 27, 2021

    ASK
    US
    PHARMACOMPASS
    Upload
    your Marketing & Sales content
    Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    euroapi-m-2024-05-06

    Access Virtual Booth

    Contact Supplier

    Send me more info on How To Grow My Business Digitally?
    Post Enquiry
    POST ENQUIRY

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search